SERA · Sera Prognostics, Inc. · Metrics
Market Cap
$80.08M
Shares
39.45M
SERA metrics
66 of 115 screener metrics currently available.
Market overview
2 metricsShare price
$2.03
Market cap
$80.08M
Price action
20 metricsPrice change (1W)
+0.5%
Price change (30D)
+3.6%
Price change (3M)
+8.6%
Price change (6M)
-4.7%
Price change (YTD)
-31.2%
Price change (1Y)
-33.9%
Trailing year
Price change (5Y)
-79.4%
52-week high
$3.75
52-week low
$1.59
Change from 52-week high
-45.9%
Change from 52-week low
+27.7%
Annualized volatility
72.4%
Annualized volatility (3M)
60.1%
Beta
0.9
RSI (14D)
49.1
Price vs SMA 50
-1.0%
Price vs SMA 200
-13.8%
Avg volume (3M)
34,095
Relative volume
0.8
Average dollar volume
$68,209
Company
3 metricsSector
Healthcare
Industry
Medical Devices
Shares outstanding
39.45M
Valuation
12 metricsP / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
1,144.0×
reciprocal yield 0.1%
P / book
1.3
reciprocal yield 74.1%
FCF yield
-35.1%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-41.5%
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
2026-08-12
Profitability
9 metricsGross margin
-150.0%
Operating margin
-53,282.9%
Trailing 12 months
Net margin
-47,475.7%
Gross profit (TTM)
—
Operating profit (TTM)
−$37.30M
Net income (TTM)
−$33.23M
Trailing 12 months
Diluted EPS (TTM)
$-0.66
FCF margin
-40,211.4%
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
+76.5%
Year over year
Net income growth YoY
—
Revenue (TTM)
$70,000
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+2.9%
Year over year · more shares
Revenue CAGR (3Y)
-32.9%
Revenue CAGR (5Y)
+26.5%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
-56.0%
Return on assets
-38.3%
Debt / equity
—
Current ratio
2.0
EBITDA (TTM)
−$36.43M
Free cash flow (TTM)
−$28.15M
Quick ratio
2.0
Interest coverage
-5,328.3
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$46.45M
Latest balance sheet
Cash & equivalents
$4.40M
Total assets
$86.74M
Total debt
—
Cash flow & spend
7 metricsOperating cash flow (TTM)
−$27.68M
Capital expenditures (TTM)
$466,000
R&D (TTM)
$13.02M
SG&A (TTM)
—
Stock compensation (TTM)
$3.93M
R&D / revenue
18,604.3%
Stock compensation / revenue
5,615.7%
Ownership (13F)
3 metrics13F filers
46
13F filer change QoQ
-10
Institutional ownership
43.2%
Short interest
3 metricsShort interest
0.6%
Latest settlement · 10.5 days to cover
Days to cover
10.5d
Short-squeeze score
62 / 100
Insider activity
2 metricsNet insider buying (90D)
−$63,274
Insider-sentiment score
31 / 100
Risk flags
1 metricsGoing concern
—
Key facts
CIK
1534969
CUSIP
81749D107
13F (30d)
13 filings
13 filers
Visit website
Investor relations